Tamar Monteiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tamar Monteiro has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
David R. Jenkins
Leicester Univ Hosp NHS Trust, Dept Clin Microbiol, Leicester, Leics, England
2 shared publicationsDeisy Gonçalves
Univ Cabo Verde, Santiago, Cape Verde
2 shared publications- Isabel Inês Araújo
Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde, Praia – Cabo Verde
2 shared publications Manish Pareek
Univ Leicester, Dept Resp Sci, Leicester, Leics, England
2 shared publications- Marco Rinaldo Oggioni
Department of Pharmacy and Biotechnology, University of Bologna , Bologna 40126
2 shared publications Sandra Beleza
Univ Leicester, Dept Genet & Genome Biol, Univ Rd, Leicester LE1 7RH, Leics, England
2 shared publications
Latest Publications
- Open Access
- 17 December 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 10) , A122.1-A122
PA-785 Characterization of anti-SARS-CoV-2 humoral immunity among health care workers in hospitals from the islands of Santiago and São Vicente, Cabo Verde
Background Health Care Workers (HCW) faced a high risk of exposure to SARS-CoV-2. In the present study, we described the presence and duration of anti-S and anti-N IgG antibodies against SARS-CoV-2 among HCW to evaluate the immunity response induced by either SARS-CoV-2 infection or COVID-19 vaccination. Methods Case-cohort study of 465 HCW from hospitals from the islands of Santiago and São Vicente, conducted in 2021, of which 217 were cases (SARS-CoV-2 infection) and 248 controls (no SARS-CoV-2 infection). Study participants were followed-up until 6 months after recruitment for longitudinal analysis of antibody dynamics, independently of SARS-CoV-2 vaccination status. ELISA test for anti-N and anti-S1 SARS-CoV-2 IgG antibodies were performed on serum samples using collected at baseline (T0) and at 6 months (T6). Among vaccinated participants, these two time points corresponded to a mean time from vaccination of 115 (SD: 60 days) and 350 days (SD: 74 days) respectively. Results Of the 396/465 (85%) tested for anti-SARS-CoV-2 antibodies at T0, 36% (n=66/185) of cases and 12% of controls (n=26/211) were positive for anti-N. Among the vaccinated at T0 165/166 (96%) cases and 200/205 (97%) controls were positive for anti-S1. The anti-S1 among the case and control group remained high at T6, with 177/179 (99%) cases and 197/198 (99%) controls of HCW tested at 6 months being positive. Among 250 (67%) vaccinated, who were anti-N negative at T0-,115(32%) remain negative at T6. Conclusion These findings showed that only 31% of cases had anti-N. The results also showed positive results for IgG anti-N in HCW without previous SARS-CoV-2 infection, which could be considered asymptomatic cases. Most vaccinated participants had Anti-S after vaccination and they remained high during the 6 months of follow-up. Nonetheless, at least (65/354) had a new infection (32 cases, 33 controls). Funding: EDCTP (RIA2020EF-3049)
- 17 December 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 10) , A122.1-A122
Open AccessPA-785 Characterization of anti-SARS-CoV-2 humoral immunity among health care workers in hospitals from the islands of Santiago and São Vicente, Cabo Verde
Background Health Care Workers (HCW) faced a high risk of exposure to SARS-CoV-2. In the present study, we described the presence and duration of anti-S and anti-N IgG antibodies against SARS-CoV-2 among HCW to evaluate the immunity response induced by either SARS-CoV-2 infection or COVID-19 vaccination. Methods Case-cohort study of 465 HCW from hospitals from the islands of Santiago and São Vicente, conducted in 2021, of which 217 were cases (SARS-CoV-2 infection) and 248 controls (no SARS-CoV-2 infection). Study participants were followed-up until 6 months after recruitment for longitudinal analysis of antibody dynamics, independently of SARS-CoV-2 vaccination status. ELISA test for anti-N and anti-S1 SARS-CoV-2 IgG antibodies were performed on serum samples using collected at baseline (T0) and at 6 months (T6). Among vaccinated participants, these two time points corresponded to a mean time from vaccination of 115 (SD: 60 days) and 350 days (SD: 74 days) respectively. Results Of the 396/465 (85%) tested for anti-SARS-CoV-2 antibodies at T0, 36% (n=66/185) of cases and 12% of controls (n=26/211) were positive for anti-N. Among the vaccinated at T0 165/166 (96%) cases and 200/205 (97%) controls were positive for anti-S1. The anti-S1 among the case and control group remained high at T6, with 177/179 (99%) cases and 197/198 (99%) controls of HCW tested at 6 months being positive. Among 250 (67%) vaccinated, who were anti-N negative at T0-,115(32%) remain negative at T6. Conclusion These findings showed that only 31% of cases had anti-N. The results also showed positive results for IgG anti-N in HCW without previous SARS-CoV-2 infection, which could be considered asymptomatic cases. Most vaccinated participants had Anti-S after vaccination and they remained high during the 6 months of follow-up. Nonetheless, at least (65/354) had a new infection (32 cases, 33 controls). Funding: EDCTP (RIA2020EF-3049)
- Open Access
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Antibiotic resistance genes and viral genomes assessment in wastewater samples from cabo verde wastewater treatment plants
Background and Objectives: Reusing treated wastewater is a sustainable and recommendable strategy, especially in a nation where water shortage is a major issue. As a result, increasing the use of treated wastewater in agriculture is a sine qua non condition. However, conventional wastewater...
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessAntibiotic resistance genes and viral genomes assessment in wastewater samples from cabo verde wastewater treatment plants
Background and Objectives: Reusing treated wastewater is a sustainable and recommendable strategy, especially in a nation where water shortage is a major issue. As a result, increasing the use of treated wastewater in agriculture is a sine qua non condition. However, conventional wastewater...
- Open Access
- 27 May 2021
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 26, 77-83
Whole-genome analysis uncovers loss of blaZ associated with carriage isolates belonging to methicillin-resistant Staphylococcus aureus (MRSA) clone ST5-VI in Cape Verde
- 27 May 2021
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 26, 77-83
Open AccessWhole-genome analysis uncovers loss of blaZ associated with carriage isolates belonging to methicillin-resistant Staphylococcus aureus (MRSA) clone ST5-VI in Cape Verde
- Open Access
- 1 September 2020
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 22, 483-487
A five-year retrospective study shows increasing rates of antimicrobial drug resistance in Cabo Verde for both Staphylococcus aureus and Escherichia coli
- 1 September 2020
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 22, 483-487
Open AccessA five-year retrospective study shows increasing rates of antimicrobial drug resistance in Cabo Verde for both Staphylococcus aureus and Escherichia coli